HVTN 144: A Clinical Trial to Evaluate Whether A Study Drug Increases Immunity in Adult Participants without HIV

Brief description of study

The HIV Vaccine Trials Network (HVTN) and the study site are doing a study to test an experimental HIV vaccine with an experimental adjuvant.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Healthy
Age: Between 18 Years - 55 Years
Gender: All

Inclusion Criteria:

18-55
Low likelihood of acquiring HIV
Negative HIV

Exclusion Criteria:

Pregnant
Clinically significant medical condition

Updated on 13 Mar 2024. Study ID: 854236

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).